Status:
COMPLETED
Multi-Center Trial of Anti-Thymocyte Globulin in Treatment of Aplastic Anemia and Other Hematologic Disorders
Lead Sponsor:
National Heart, Lung, and Blood Institute (NHLBI)
Conditions:
Anemia, Aplastic
Hematologic Diseases
Eligibility:
All Genders
18-75 years
Phase:
PHASE3
Brief Summary
To determine the therapeutic effects of anti-thymocyte globulin (ATG) in patients with aplastic anemia and related bone marrow failure diseases.
Detailed Description
BACKGROUND: Aplastic anemia has been shown to respond to ATG. An immunological basis for aplastic anemia has been suggested by previous observations although the precise mechanism of action of ATG ha...
Eligibility Criteria
Men and women with moderate or acute, severe, aplastic anemia.
Key Trial Info
Start Date :
March 1 1982
Trial Type :
INTERVENTIONAL
End Date :
December 1 1988
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00000597
Start Date
March 1 1982
End Date
December 1 1988
Last Update
November 26 2013
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.